Keywords: satraplatin, cuts, progression, prostate, cancer, german, drugmaker

Satraplatin cuts progression in prostate cancer

Article | 11 June 2007

Print This

German drugmaker GPC Biotech and USA-based pharmaceutical firm Pharmion say that data from a trial of their co-developed oncology drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in